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A metabolomics method based on ultra high performance liquid chromatography with
quadrupole time-of-flight mass spectrometry was developed to evaluate the influence
of processing times on the quality of raw and processed Polygoni Multiflora Radix.
Principal component analysis and partial least-squares discriminant analysis was used
to screen the potential maker metabolites that were contributed to the quality changes.
Then these marker metabolites were selected as variables in Fisher’s discriminant
analysis to establish the models that were used to distinguish the raw and processed
Polygoni Multiflora Radix in the markets. Additionally, 36 compounds were identi-
fied. Twelve raw Polygoni Multiflora Radix samples and 23 processed Polygoni Mul-
tiflora Radix samples were distinguished. The results showed that the 12 raw Polygoni
Multiflora Radix samples belonged to the group of processing time of 0 h, and two
processed Polygoni Multiflora Radix samples were part of the group of processing
times of 4 h, 12 samples belonged to group of processing times of 8 to 16 h, and nine
samples were the group of processing times of 24 to 48 h. The results demonstrated
that the method could provide scientific support for the processing standardization of
Polygoni Multiflora Radix.
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1 INTRODUCTION
Traditional Chinese medicines (TCMs) have been used for
the prevention and treatment of a variety of diseases for
quite a long time. At present, TCMs have gained more and
more attention with the increased awareness of healthcare
among people. According to the TCM theory, raw materials
Abbreviations: FDA, Fisher’s discriminant analysis; PMR, Polygoni
Multiflora Radix; PCA, principal component analysis; PLS-DA, Partial
Least Squares Discriminant Analysis; VIP, variable importance parameters
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sometimes need to be processed by heating, steaming and
soaking to enhance efficacy or reduce toxicity before they
were used in the TCM prescriptions [1]. Nowadays, many
TCM and their processed products are commercially available
in the markets of China.
Polygoni Multiflora Radix (Heshouwu in Chinese, PMR)
was one of widely used TCMs, which was used for the treat-
ment of hyperlipidemia, heart disease and other diseases asso-
ciated with aging [2,3]. The main components in PMR con-
sist of stilbenes, anthraquinones, phenolicacids, flavonoids
and their glycosides [4,5]. Studies have shown that stilbenes
have the anti-aging, anti-inflammatory, anti-oxidative and
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liver-protective activities [6,7]. Anthraquinone possessed the
activities of anti-bacterial, anti-fungal, antioxidant and anti-
cancer [8]. Phenolic acids and flavonoids exhibited the
antioxidant activity in vitro and in vivo [9]. It was these
components contribute to the pharmacological activities of
PMR. According to Chinese Pharmacopoeia, the raw Poly-
goni Multiflora Radix (R-PMR) was processed by steam-
ing with black bean juice, which was named as the pro-
cessed Polygoni Multiflora Radix (Zhishouwu in Chinese,
P-PMR). Previous reports showed that the contents of some
compounds were enhanced or decreased during the process-
ing of R-PMR [10]. The changes might be responsible for
the changes of the pharmacological effects of R-PMR and
the hepatotoxicity [11]. Since the processing of TCMs could
result in the components changes and the changes could
result in different pharmacological activities, it is neces-
sary to characterize the processing state of PMR for more
safe and efficacious use. Currently, R-PMR and P-PMR are
of commercially availability in the herbal markets. How-
ever, there is no exact standard to abide for the process-
ing of PMR. Thus, it is urgent to develop a method to
establish a processing standard for the QC of PMR in the
markets.
Metabolomics is considered as a systematic approach to
deal with parallel assessment of the levels of a variety of
metabolites and have played an important role in both phe-
notyping and diagnostic analyses in plants [12]. These meth-
ods have been applied for the assessment of natural variance
in metabolite composition [12]. Nowadays, modern analyti-
cal techniques like HPLC–MS, UHPLC–MS and GC–MS are
used inmetabolomics studies [13]. Among the analytical tech-
niques in metabolomics researches, UHPLC–MS is taken as
one of the best analytical methods with high sensitivity, selec-
tivity and reproducibility [14,15]. Moreover, the combination
of metabolomics techniques with chemometric method could
provide a fast reliable method for the biomarker screening,
component identification and QC of TCMs [16].
In the study, a simple and reliable UHPLC–Q-TOF-
MS-based metabolomics method was developed and vali-
dated to evaluate the influence of different processing times
on the quality of PMR. Furthermore, principal component
analysis (PCA) was used to select influential biochemical
markers for distinction of the sample groups. The Fisher’s
discriminant analysis (FDA) was applied to establish the
standard models by using the screened biochemical markers
in the different processing times of PMR samples. Finally, the
discriminant models were used to distinguish the PMR in the
markets to standardize the process of PMR. That is, super-
vised and unsupervised methods of data analysis were used to
discriminate PMR samples with different processing times.
Overall, the Q-TOF-MS-based metabolomics approach could
be used to provide general quality evaluation of PMR in the
markets.
2 MATERIALS AND METHODS
2.1 Plant materials
R-PMR and P-PMR samples were purchased from Tianjin
pharmacy and authenticated by Dr. Yan-xu Chang (Tianjin
University of Traditional Chinese Medicine). The voucher
specimens were deposited at Tianjin University of Traditional
Chinese Medicine, Tianjin, China.
2.2 Chemicals and reagents
Acetonitrile was purchased from Merck (Darmstadt,
Germany) and methanol of HPLC grade was obtained
from Tianjin Concord Science (Tianjin, China). Formic
acid of HPLC grade was purchased from Tedia (Fairfield,
OH, USA). Deionized water was purified with a Milli-Q
Academic ultra-pure water system (Millipore, Milford, MA,
USA). Reference Standards of gallic acid, catechin, epi-
catechin, 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside,
resveratrol, emodin-8-O-glucoside, physcion-8-O-glucoside,
rhein and emodin (purity > 98%)were purchased from
Chengdu Must Biotechnology (Chengdu, China). Other
reagents were of analytical grade and obtained commercially.
2.3 Sample preparation
2.3.1 Preparation of P-PMR extract
P-PMR was processed by black soybean decoction accord-
ing to Chinese Pharmacopoeia. The processing procedure was
as follows: 2 kg R-PMR was mixed with black beans extract
(0.2 kg black beans were extracted with some water for 4 h for
0.3 kg decoction, then the soybean dregs were continued to
be boiled by water for 3 h for 0.2 kg decoction. Finally 0.5 kg
black soybean decoction were obtained) and then steamed in
the steamer by boiling water for different times. Finally the
P-PMR samples of different times at 4, 8, 12, 16, 24, 32, 40
and 48 h were obtained. The raw RPM was named as the
P-RPM samples at 0 h processing time.
The dried powder of R-PMR and P-PMR (0.1 g) samples
were weighed accurately and extracted with 10 mL 70% v/v
methanol ultrasonically for 20 min. After centrifugation at
14 000 rpm for 10 min, the supernatants were filtered through
0.22 μm filter [5]. Then the extracts of R-PMR and P-PMR
which was prepared with different processing times were
obtained.
2.3.2 Preparation of standard solutions
Gallic acid, catechin, epicatechin, 2,3,5,4-tetrahydroxy-
stilbene-2-O-β-D-glucoside, resveratrol, emodin-8-O-gluco-
side, physcion-8-O-glucoside, rhein and emodin with the
concentration of 1.0 mg/mL were prepared in methanol. The
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reference standards solution was diluted serially to achieve
the standard working solutions.
2.4 UHPLC–Q-TOF-MS analysis
Aglient 6520 Q-TOF mass spectrometer (Agilent Corpora-
tion, Santa Clara, CA, USA) coupled with the Agilent 1290
UHPLC by an ESI interface was used to identify the com-
ponents in PMR extract. The chromatographic and ESI-MS
spectra conditions were used to separate and identify the
markers and components in sample according to our previous
study [17].
2.5 Method validation
The method validation included precision, repeatability and
stability. The mixed standard solutions were used for method
validation. The precision was investigated by one sample with
six replicate injections. The repeatability of the method was
assessed by performing six replicate solutions. The stability
of those analytes was assessed by analyzing the solution at 0,
2, 4, 6, 8, 12 and 24 h. The validation was expressed as the
RSD.
2.6 Data analysis
For the metabolite profiling of R-PMR and P-PMR, the
UHPLC–Q-TOF-MS data were analyzed by the XCMS soft-
ware operating on the R + package (R Foundation for Statis-
tical Computing, Vienna, Austria). The intensities of detected
peaks were tabulated using tR-m/z pairs and exported for
statistical analyses. Data processing, which included han-
dling missing values and normalizing the data set, was per-
formed to convert the data into the proper data sets [18,19].
After data processing, chemometrics methods were applied to
the data sets to select influential metabolites for discrimina-
tion of the sample groups. All processed data were analyzed
using principal component analysis (PCA) to discriminate raw
and processed PMR in the TCM markets and select influen-
tial metabolites. Partial Least Squares Discriminant Analysis
(PLS-DA) was used to test the classification performance of
discriminant P-PMR samples of different processing times.
Then the selected metabolites were applied in the Fisher′s
discriminant analysis (FDA) for the establishment of the dis-
criminant models by the P-PMR samples of different process-
ing times. Finally the models were used to classify the PMR
samples in the markets. The PCA and PLS-DA were analyzed
by Simca P version 11.5 (Umetrics, Umea, Sweden) and FDA
was analyzed by SPSS version 19.0 (SPSS, Chicago, IL, USA)
for data analysis.
F IGURE 1 The total ion chromatogram (TIC) of the main compo-
nents in Polygonum multiflorum extract (A) and the representative chro-
matograms of the 4 groups. B1(R-PMR processed for 0 h), B2 (P-PMR
processed for 4 h), B3(P-PMR processed for 8–12 h) and B4(P-PMR
processed for 16–32 h).(M1-M14 present M683, M684, M377, M379,
M404, M133, M169, M179, M389, M439, M440, M341, M278 and
M215)
3 RESULTS
3.1 Optimization of UHPLC–Q-TOF-MS
analysis conditions
The UHPLC–Q-TOF-MS analytical method was developed
for the better resolution and detection of a wide range of
metabolites in the PMR. The optimization of mass conditions
was performed in negative ion mode for this ion mode pro-
vided more information on analyzing the PMR extract. Sol-
vent systems including acetonitrile/water and methanol/water
in different proportions and gradient durations were tried.
As a result, acetonitrile/water containing 0.1% formic acid
was selected as mobile phases. What is more, other chro-
matographic conditions, like columns, column temperatures
and flow rates were also optimized. Among the several con-
ditions tested, an ACQUITY UHPLC BEH C18 (1.7 μm,
2.1 × 50 mm) column at column temperature of 30°C reached
the better performance. The flow rate was set at 0.3 mL/min.
A representative chromatogram of PMR is shown in Fig. 1A.
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TABLE 1 The method validation of UHPLC-Q-TOF/MS
Compound
Precision
(RSD%)
Repeatability
(RSD%)
Stability
(RSD%)
Gallic acid 2.32 1.91 2.56
Catechin 3.00 2.40 2.49
Epicatechin 1.83 2.82 2.56
PM-SG 1.10 2.63 2.79
Resveratrol 2.41 2.64 3.27
Emodin-8-O-
glucoside
2.26 2.34 2.13
Physcion-8-O-
glucoside
2.40 2.12 2.14
Rhein 1.83 2.49 2.68
Emodin 1.77 1.49 2.86
3.2 Method validation
To validate the developed method, the precision, repeatabil-
ity and stability of the metabolite profiling study was car-
ried out. Nine representative reference standards were used
for the method validation. The results were listed in Table 1.
As shown in Table 1, the RSD values of precision were less
than 3.0%, indicating that the method was precise for the qual-
itative analysis of PMR extract. The results of the repeatabil-
ity were no more than 2.82%, which demonstrated that the
method was reproducible for compound identification. The
RSDs of the stability of the analytes were less than 3.27%,
demonstrating the sample solutions were stable with 24 h
at room temperature. The above results demonstrated that
UHPLC–Q-TOF-MS method could be used for the metabo-
lite profiling study of PMR extract.
3.3 Multivariate statistical analysis
We analyzed 12 R-PMR and 23 P-PMR samples by the
UHPLC–Q-TOF-MS method. All chromatographic informa-
tion obtained from the metabolite profiling of 35 PMR
samples were analyzed by the XCMS software. A three-
dimensional data matrices containing sample information,
variables characterized by retention time andm/z value as well
as their corresponding intensities were obtained and exported
to an Excel table. The data were preprocessed following the
method described previously [20]. Moreover, the p values in
t-test also were given. Totally 1256 processed and treated
metabolites with p values less than 0.05 were selected out
for the PCA analysis to determine the similarities and differ-
ences among the 35 PMR samples. It was not observed that
the new components were obviously produced during the pro-
cessing. As shown in Fig. 2, the three-dimensional PCA score
plot showed a fairly clear differentiation between R-PMR and
P-PMR.
F IGURE 2 The score plot of the PCA of samples based on the
1256 variables with p < 0.05
To select influential metabolites for the discrimination, the
datasets were applied to the statistical classification method.
As a result, 35 metabolites (M115, M121, M128, M133,
M169, M179, M186, M191, M195, M215, M269, M270,
M278, M283, M289, M290, M341, M377, M379, M389,
M404, M407, M419, M431, M439, M440, M441, M511,
M517, M564, M683, M684, M811, M813 and M863), the
key constituents for the discrimination of R-PMR and P-PMR,
were selected from 1256 metabolites. The results were shown
in Fig. 3. Furthermore, PLS-DA model was used to select key
markers from these 35 metabolites. This stems from the fact
that it can select markers depending on variable importance
parameters (VIP > 1) which can then be used to be selected
as markers according to the order of their contributions to
the separation of clustering. Based on the VIP, 15 metabo-
lite markers can be screened. The results are shown in Fig. 3.
It was illustrated that 15 metabolite markers were regarded to
be the components which contributed most to discrimination
of R-PMR and P-PMR.
3.4 Compound identification in PMR extract
The identification of the components in PMR extract was car-
ried out by UHPLC–Q-TOF-MS. The 70% methanol extract
of PMR was employed to obtain the total ion chromatogram
(TIC) of MS study and MS/MS study of the fragment ion. As
can be seen from Table 2, 36 compounds were identified or
characterized tentatively according to previous reports
3.4.1 Identification of gallates and tannins
Seven gallates and tannins were detected, including gallic acid
and monomers, dimmers and trimers of catechin/epicatechin
units. The identification of tannins was conducted by com-
paring the MS/MS fragmentation information with previous
reports [21,22]. MS/MS spectra of negative mode produced
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F IGURE 3 The results of screened marker metabolites and the numbers present the molecular weight of metabolites and one circle presents a
metabolite and the results of screened marker metabolites and the selected 15 marker metabolites according to VIP value (>1)
abundant ions, which were listed in Table 2. Compounds 2, 4,
5 and 13 were identified unambiguously by comparing with
the reference compounds. They were identified as gallic acid,
catechin, epicatechin and catechin gallate, respectively [17].
The component 35 was identified by extracting ion at m/z 577
from TIC. The precursor ion at m/z 577 (C30H25O12) was
founded in MS spectra and most abundant ion at m/z 425 was
given in MS/MS spectrum. The fragment ions at m/z 289 and
287 could be attributed to the quinonemethide fission cleav-
age of the type-B interflavan bond resulting from the loss of
an epi/catechin residue. As a result, it was identified as pro-
cyanidin B by comparing the MS information with the litera-
ture [23]. A predominant peak of compound 29 was screened
out by parents scan for ion at m/z 289. Compound 29 was
identified as a trimer of catechin for its characteristic fragment
ions of m/z 577 and m/z 289, which were the successive losses
of catechin unit [24]. In addition, another trimerepi/catechin
was detected by selecting the corresponding high-resolution
[M–H]– precursor ions in negative mode. Thus, compound 30
was identified as prodelphinidin tentatively [23].
3.4.2 Identification of stilbenes
2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside (11, THSG)
gave a [M–H]– ion at m/z 405 and [2M–H]– at 811 in the
negative mode. In the MS/MS spectrum, THSG gave a dom-
inant ion at m/z 243, which could be recognized as the diag-
nostic ion for stilbenes. Further fragmentation produced four
most abundant ions at m/z 225, 215, 149 and 137. Compound
1 gave a [M–H]–ion at m/z 403 in MS spectrum and promi-
nent fragment ion at m/z 241 in MS/MS spectrum, which
were the loss of two glc units from THSG. Furthermore, the
loss H2O and CO of fragment ion at m/z 241 formed the
ions at 223 and 213, respectively. The consecutive loss of
CO produced ions at m/z 195 and 169. Compound 1 was
identified as tetrahydroxy-phenanthrene -O-hexoside prelimi-
narily [23]. Compound 9 gave a [M–H]– ion at m/z 567 in the
MS spectrum. The consecutive loss of hexoside form edion-
sat m/z 405 and 243 in MS/MS spectra. It was characterized
astetrahydroxystilbene-O-dihexoside by comparing previous
report [25,26]. Compounds 14 and 15 have the same [M–H]–
ion atm/z 557 in MS spectra and identical ions atm/z 313, 405
and 243 in MS/MS spectra. The ion at m/z 405 was produced
by the loss of C7H4O4 and ion at m/z 313 produced gallic
acid deprotonated ion at m/z 169. By comparing the informa-
tion with literatures, compounds 14 and 15 were identified as
astetrahydroxystilbene-O-(galloyl)hexosides [27]. Compound
17 showed the [M–H]– ion at m/z 421 and [M + HCOO]−
ion at m/z 467 in MS spectra. Owing to the hexose loss, the
prominent ion at m/z 259 was produced. Compared with the
previous report, compound 17 was characterized as pentahy-
droxystilbe neglucoside tentatively [26]. Compound 20 gave
an ion of [M–H]– at m/z 551 and characteristic ion at m/z
243 was produced by the losses of C9H6O2 and C6H10O5 in
MS/MS spectra. A minor ion atm/z 307 was also observed. As
a result, compound 20 was identified as tetrahydroxystilbene-
O-(coumaroyl) hexoside tentatively [28]. For the detection of
loss of feruloyl moiety C10H8O3, compound 19 was tenta-
tively characterized as tetrahydroxystilbene-O-(feruloyl) hex-
oside similar to compound 20 [29]. Compound 10 was iden-
tified as polydatin according to previous research [17,26].
Compound 18 was identified as resveratrol by comparing it
with the reference standard.
3.4.3 Identification of anthraquinones
Physcion (34) showed the [M–H]– ion at m/z 283 and yielded
the ion at m/z 268 for the loss of CH3 free radical. The
ions at m/z 240, 212 and184 were produced by the further
elimination of CO. Emodin (33) gave an [M–H]– ion at m/z
YU ET AL. 1933
TABLE 2 The identification of compounds in R-PMR and P-PMR-extract
No. [MS−] MS/MS ppm Formula Compound
1 0.786 403.1056 241.1022, 213.1123,
223.0221, 195.0324,
169.1231
0.21 C20H20O9 Tetrahydroxy-phenanthrene-
O-hexoside
2 1.409 169.0141 6.6 C7H6O5 Gallic acid
3 2.116 419.1653 213.1233, 195.1119,
128.0349, 101.0712
1.5 C20H21O8 Rhaponticoside
4 3.725 289.0724 215.0714, 173.0535,
149.0206, 125.0215,
109.0283
2.2 C15H14O6 Catechin
5 4.48 289.0724 276.4677, 205.0499,
163.0368, 131.0053,
109.0317
2.2 C15H14O6 Epicatechin
6 4.542 393.1603 231.1265, 187.1096,
189.0750
1.94 C19H20O9 Hydroxymusizin-O-hexoside
7 4.963 269.0120 240.0555, 211.1021 3.89 C15H10O5 Aloe-emodin
8 5.081 531.1498 487.0979, 283.0637,
239.0802
1.88 C26H28O12 Physcion-8-O-(6′-O-
malonyl)-glucoside
9 6.227 567.1719 405.1198, 243.0657,
215.1021, 149.0245
0.05 C26H32O14 Tetrahydroxystilbene-O-di-
hexoside
10 6.484 389.1168 3.89 C20H22O8 Polygonin
11 6.748 811.0644 405.1180, 243.0648,
225.3022, 215.1024,
149.2312, 137.0237
1.03 C20H22O9 2,3,5,4
′-Tetrahydroxystil-
bene-2-O-β-D-glucoside
12 7.145 407.1184 245.0656, 230.0237,
215.1011
0.95 C20H24O9 Torachrysone-8-O-glucoside
13 7.574 441.0853 331.1021, 289.0023,
169.3201
2.31 C22H18O10 Catechingallate
14 7.728 557.1162 405.1142, 313.0542,
243.0645, 169.0130
2.49 C27H26O13 Tetrahydroxystilbene-O-
(galloyl)-hexoside
15 7.970 557.1034 405.1172, 313.0550,
243.0646, 169.0125
2.49 C27H26O13 Tetrahydroxystilbene-O-
(galloyl)-hexoside
16 8.433 121.0295 92.0254, 65.0383 2.06 C7H6O2 p-Hydroxybenzaldehyde
17 8.681 421.1146/
467.0823
259.0563 1.43 C20H22O10 Pentahydroxystilbene-O-
hexoside
18 9.242 227.2002 202.0698, 176.0559,
99.9223, 91.0179, 73.5614
3.35 C14H12O3 Resveratrol
19 9.865 581.1636 387.1131, 331.0592,
243.0638, 405.0387
4.9 C30H30O12 Tetrahydroxystilbene-2-O-
(feruloyl)-hexoside
20 10.202 551.1551 405.1134, 307.0819,
243.0658
0.57 C29H28O11 Tetrahydroxystilbene-2-O-
(coumaroyl)-hexoside
21 10.472 407.1336 245.0800, 230.0568,
215.0348
0.12 C20H24O9 Torachrysone-8-O-β-D-
glucoside
22 10.597 863.2053/
431.1386
269.0448, 225.0540 0.86 C21H20O10 Emodin-8-O-glucoside
(Continues)
269, which formed two prominent ions at m/z 225 and 241
by the loss of a CO and CO2, respectively. Two ions at m/z
181 (loss of a CO2) and 210 (loss of a methyl free radical)
were determined from the ion of m/z 225. The ion at m/z
197 was generated by the loss of CO2from ion at m/z 241.
Chrysophanol (compound 36) showed the [M–H]– ion at m/z
253 in the negative mode and prominention at m/z 225 due to
loss of CO in MS/MS spectra. Ions at m/z 210 and 181 were
resulted from the losses of a methyl radical and CO2 molecule
of the ion at m/z 225. Aloe-emodin (7) has the same [M–H]–
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TABLE 2 (Continued)
No. [MS−] MS/MS ppm Formula Compound
23 11.324 517.1009 473.1057, 269.0443 0.44 C24H22O13 Emodin-O-(malonyl)-
hexoside
24 11.634 285.0380 257.0407, 241.0483,
211.0384, 268.0361
0.7 C25H10O6 Citreorosein
25 11.786 445.0595 283.0595, 240.0415 0.76 C21H20O10 Physcion-8-O-glucoside
26 12.241 473.1089 377.0121, 269.0453 0.48 C23H22O11 Aloe-emodin-8-O-(6‘-O-
acetyl)-glucoside
27 12.596 329.2322 229.1418, 211.13, 183.1392,
99.0808, 57.0335
1.44 C17H14O7 Aurantio-obtusin
28 12.794 473.1124 311.1052, 269.0477,
207.8834, 102.9316
1.02 C23H22O11 Acetyl emodin-O-hexoside
29 13.339 865.2084 577.0965, 289.0433 1.48 C42H40O20 Trimer of catechin
30 13.934 865.2053 577.0925, 289.1403 1.48 C42H40O20 Prodelphinidin
31 14.127 283.0606 240.0409 3.76 C15H8O6 Rhein
32 15.879 447.1321 243.9898 4.4 C22H23O10 Tetrahydroxystilbene-O-
(acetyl)-hexoside
33 17.188 269.0460 241.0491, 225.0549,
210.0312, 197.0598,
181.0122
3.89 C15H10O5 Emodin
34 18.939 283.0399 268.1120, 240.0482,
212.1121, 184, 0213
0.88 C16H12O5 Physcion
35 20.596 577.1357 425.0873, 289.1143,
287.0559
1.82 C30H26O12 Procyanidin B
36 21.417 253.2173 225.0423, 210.0111,
181.1011
1.9 C15H10O4 Chrysophanol
ion at m/z 269 and molecular composition with emodin. The
ion at m/z 240 was generated by the loss of CHO from m/z
269 in the MS/MS spectra, from which generated the ion at
m/z 211 by the loss of CHO. Physcion-8-O-glucoside (25),
emodin-8-O-glucoside (22), rhein (31) and citreorosein (24)
were identified by comparing the chemical information with
reference standard compounds. Compound 23 gave a [M–
H]– ion at m/z 517. The malonyl substituent on the glycosyl
residue was deduced by further elimination of CO2 in MS/MS
spectra. It was identified as emodin-O-(malonyl) hexoside by
comparing the MS data with that of a previous report [23].
Compound 28 showed the [M–H]– ion at m/z 473 and an ion
at m/z 311 by the loss of hexose unit in MS/MS spectra and
then produced the ion at m/z 269 for further fragmentation.
Compound 28was likely to be acetylemodin-O-hexoside [23].
Compound 26 exhibited a [M–H]– ion at m/z 473 in MS spec-
tra and ions atm/z 377 and 269 in MS/MS spectra. By compar-
ing the MS data with literature, compound 26 was identified
as aloe-emodin-8-O-(6′-O-acetyl)-glucoside tentatively [29].
Compound 8 gave a [M–H]– ion at m/z 531 in the full scan
of PMR extract. The ion at m/z 487 and 283 was produced
by the loss of CO2 and malonylglucosyl from the precursor
ion in MS/MS spectra, respectively. Moreover, the ion at m/z
239 was got by the loss of CO2 from the ion at m/z 283.
As a result, compound 8 was identified as physcion-8-O-(6′-
O-malonyl)glucoside according to the literature [30].
3.4.4 Identification of naphthalenes
As far as we know, torachrysone-8-O-glucoside (12 and
21) was the only naphthaleneglycoside in PMR [23].
Torachrysone-8-O-glucoside, the [M–H]– ion at m/z 407 lost
one glucosyl residue to generate the prominent ion at m/z 245
and then eliminated CH3 free radical to produce the ion at m/z
230. For acetyl torachrysone glycoside, the ion at m/z 245and
characteristic ions at m/z 230 and 215 by loss of two CH3 free
radicals was observed. Thus compound 32 was identified ten-
tatively as torachrysone-O-(acetyl)hexoside [31]. Compound
6 showed the [M–H]– ion at m/z 393 in the MS spectrum
and then eliminated a hexose unit to produce the ion at m/z
231. The ion at m/z 231 continued to lose the CO2 and
CH2CO to generate the ion at m/z 187 and 189, respectively.
As a result, it was identified as hydroxymusizin-O-hexoside
tentatively [23].
3.4.5 Identification of other compounds
Apart from the identified compounds above, several other
compounds (3, 16 and 27) were also identified in the study.
Their chemical information is listed in Table 2.
YU ET AL. 1935
3.5 Structural study of selected marker
metabolites
From the PCA results above, 35 maker metabolites (M115,
M121, M128, M133, M169, M179, M186, M191, M195,
M215, M269, M270, M278, M283, M289, M290, M341,
M377, M379, M389, M404, M407, M419, M431, M439,
M440, M441, M511, M517, M564, M683, M684, M811,
M813 and M863) were selected out for the discrimination
of R-PMR and P-PMR. The results are listed in Table 3.
Among the 35 maker metabolites, 15 compounds were identi-
fied according to our results of qualitative analysis. The other
20 compounds are still unknown and our identification work
will continue.
3.6 Discriminant analysis
In the study, unsupervised principal component analysis
(PCA) was firstly applied to investigate the known 29
P-PMR samples at different processing times (0, 4, 8, 12,
16, 24, 32, 40 and 48 h) according to 15 maker metabo-
lites. As shown in Fig. 4A, under the unsupervised model,
29 P-PMR samples at different processing time can be pre-
liminary divided into four different groups depending on
distribution property, which illustrated that P-PMR samples
with different processing time at 0, 4, 8–16 and 24–48 h
can be clustered. After prediction, the discriminant analy-
sis was used to build the predictive model of the group
membership based on observed characteristics of variables.
It produced a discriminant function (for more than two
groups, a set of discriminant functions) based on the pre-
dictor variables that provide the discrimination among the
groups. The discriminant functions were generated by the
samples with known groups. Then discriminant functions
were used to predict the predictor variables with unknown
groups.
Here, 29 P-PMR samples were collected at different pro-
cessing times (0, 4, 8, 12, 16, 24, 32, 40 and 48 h), and PLS-
DA [32,33] model was applied again to validate whether they
could be separated according to 35 markers and 15 markers.
As obviously shown in Fig. 4B and Fig. 4C, 4 groups (0 h to
one group, 4 h to one group, 8 to 16 h to one group and 24 to
48 h to the last group) were separated well depending on 15
markers as same as using 35 markers. Therefore, 15 metabo-
lite markers can be used as variables for the establishment
of the discriminant function. However, not all variables could
be used for the establishment of the discriminant func-
tion. Only the valuable predictor variables were of impor-
tance to the generation of the discriminant functions. After
the discriminant analysis using the SPSS software, only
14 variables were selected for the establishment of the
discriminant function. The four discriminant functions of
PMR generated from the different processing times were
as follows:
Group1 = 0.000065885295𝑥1 + 0.000086776115𝑥2
−0.000000756662𝑥3 − 0.000157974117𝑥4
−0.001301271997𝑥5 + 0.000046073611𝑥6
−0.000024018062𝑥7 + 0.000042095163𝑥8
−0.000673736933𝑥9 + 0.000004711657𝑥10
−0.000042310637𝑥11 + 0.000283186084𝑥12
+0.000006733512𝑥13 − 0.000029951111𝑥14
−518.485421295047
Group2 = 0.00004582315𝑥1 + 0.000132116003𝑥2
−0.00014813681𝑥3 − 0.000157679338𝑥4
+0.000624415946𝑥5 + 0.000071567204𝑥6
−0.000039769481𝑥7 + 0.000100790637𝑥8
−0.001579335678𝑥9 + 0.000002449869𝑥103
−0.000046686166𝑥11 + 0.000337252255𝑥12
+0.000002219651𝑥13 − 0.000036448989𝑥14
−696.409882440827
Group3 = 0.000050911879𝑥1 + 0.000064893671𝑥2
−0.000026210477𝑥3 − 0.000101949668𝑥4
−0.000689318802𝑥5 + 0.000033893287𝑥6
−0.000021532886𝑥7 + 0.000041543332𝑥8
−0.000488599467𝑥9 + 0.000003184608𝑥10
−0.000034489071𝑥11 + 0.000230166438𝑥12
+0.000004439329𝑥13 − 0.000022758896𝑥14
−297.312167291817
Group4 = 0.000068735928𝑥1 + 0.00008846915𝑥2
−0.000048268874𝑥3 − 0.00011361905𝑥4
−0.001528276717𝑥5 + 0.000027687492𝑥6
−0.000014014032𝑥7 + 0.000018717914𝑥8
−0.00085575779𝑥9 + 0.000004890566𝑥10
−0.000031915674𝑥11 + 0.00023368023𝑥12
+0.000008409557𝑥13 − 0.000018287617𝑥14
−376.383930338424
Where Group 1 denotes samples of 0 h, Group 2 denotes
samples of 4 h, Group 3 denotes samples of 8 to 16 h
and Group 4 denotes samples of 24 to 48 h; x1 to x14
represents M133, M169, M179, M215, M278, M341,
M377, M379, M389, M404, M439, M440, M517, M683.
Finally, the classification result showed that 100% of orig-
inally grouped cases were correctly classified and 95.1%
of cross-validation grouped cases were further correctly
classified. The above results demonstrated that the dis-
crimination model was reliable. The samples belonged to
the group where the calculated value of the functions was
the highest. The detailed data of four different discrimi-
nant function scores of 29 samples are shown in Table 4.
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TABLE 3 The screened maker metabolites for the discrimination of R-PMR and P-PMR
No. Marker Rt. MS MS/MS ppm Formula Compound
1 M115 0.601 115.0022 Unknown
2 M683 0.669 683.2240 Unknown
3 M684 0.669 684.2269 Unknown
4 M377 0.702 377.0871 179.0354, 119.0345,
101.0233, 89.0248,
71.0136, 59.0146
Unknown
5 M379 0.702 379.0831 179.0354, 119.0345,
101.0233, 89.0248,
71.0136, 59.0146
Unknown
6 M404 0.786 404.1061 61.9891 Unknown
7 M133 0.801 133.0145 Unknown
8 M191 0.920 191.0205 57.0357, 85.0304,
87.0089, 111.0076
Unknown
9 M169 1.409 169.0141 6.6 C7H6O5 Gallic acid
10 M128 1.796 128.0354 109.6663, 103.2380,
67.9247, 60.9239
Unknown
11 M419 2.205 419.1682 Unknown
12 M186 3.464 186.0555 142.0656, 116.0488 Unknown
13 M179 3.543 179.0549 Unknown
14 M289 3.725 289.0724 215.0714, 173.0535,
149.0206, 125.0215,
109.0283
2.2 C15H14O6 Catechin
15 M289 4.48 289.0724 276.4677, 205.0499,
163.0368, 131.0053,
109.0317
2.2 C15H14O6 Epicatechin
16 M195 5.724 195.0508 Unknown
17 M389 6.484 389.1168 3.89 C20H22O8 Polygonin
18 M439 6.748 439.0816 Unknown
19 M811 6.748 811.0644 405.1180, 243.0648,
225.3022, 215.1024,
149.2312, 137.0237
1.03 C20H22O9 2,3,5,4
′-Tetrahydroxystil-
bene-2-O-β-D-glucoside
20 M813 6.748 813.0644 405.1180, 243.0648,
225.3022, 215.1024,
149.2312, 137.0237
1.03 C20H22O9 2,3,5,4
′-Tetrahydroxystil-
bene-2-O-β-D-glucoside
21 M407 7.145 407.1184 245.0656, 230.0237,
215.1011
0.95 C20H24O9 Torachrysone-8-O-glucoside
22 M440 7.574 441.0853 331.1021, 289.0023,
169.3201
2.31 C22H18O10 Catechingallate
23 M441 7.574 441.0853 331.1021, 289.0023,
169.3201
2.31 C22H18O10 Catechingallate
24 M121 8.433 121.0295 92.0254, 65.0383 2.06 C7H6O2 p-Hydroxybenzaldehyde
25 M341 8.714 341.1097 249.0698, 89.0241,
59.0141
Unknown
26 M511 9.655 511.0576 431.0976, 121.0283 Unknown
(Continues)
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TABLE 3 (Continued)
No. Marker Rt. MS MS/MS ppm Formula Compound
27 M431 10.597 431.1386 269.0448, 225.0540 0.86 C21H20O10 Emodin-8-O-glucoside
28 M517 11.324 517.1009 473.1057, 269.0443 0.44 C24H23O13 Emodin-8-O-(6′-O-
malonyl)-glucoside
29 M865 13.934 865.2053 577.0925, 289.1403 1.48 C42H40O20 Prodelphinidin
30 M269 17.188 269.0460 241.0491, 225.0549,
210.0312, 197.0598,
181.0122
3.89 C15H10O5 Emodin
31 M270 17.188 270.0496 241.0491, 225.0549,
210.0312, 197.0598,
181.1021
3.89 C15H10O5 Emodin
32 M564 18.708 564.3323 Unknown
33 M283 18.939 283.0399 268.1120, 240.0482,
212.1121, 184, 0213
0.88 C16H12O5 Physcion
34 M278 20.872 278.0894 Unknown
35 M215 22.489 215.0327 Unknown
F IGURE 4 PCA model for known 29 samples at different processing times (0, 4, 8, 12, 16, 24, 32, 40, and 48 h) and prediction for clustering
another four groups (A); the PLS-DA model for 29 samples of four different processing times depending on 35 maker metabolites (B); the PLS-DA
model for 29 samples of four different processing times depending on 15 maker metabolites (C)
From the discriminant functions, only 14 variables were
used to produce the functions. 35 PMR samples (12 R-PMR
and 23 P-PMR) from different pharmacies in Tianjin were dis-
tinguished by the discriminant functions. The values of the
15 variables were put into the four discriminant functions to
describe which group the 35 samples was classified into. The
samples belonged to the group where the calculated value of
the functions was the highest. The results demonstrated that
the R-PMR and P-PMR samples from different pharmacies in
Tianjin were clustered into the group of processing times of
0 and 4–48 h, respectively, further illustrating that the models
established by the discriminant analysis were accurate. As far
as the P-PMR samples are concerned, they were divided into
three parts. The detail results of prediction of 35 samples are
shown in Table 5. Two P-PMR samples were clustered into the
group of processing time of 4 h, 12 samples belonged to the
group of 8–16 h and nine samples were divided into the group
of 24–48 h. The results demonstrated that the established dis-
criminant models could be used to standardize the processing
of PMR in the market.
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TABLE 4 The 4 different discriminant functions scores of 29 samples
Discriminant functions score
Sample name Group1 Group2 Group3 Group4 Classified
0h–1 525.5789 444.8304 473.3899 429.3605 Group 1
0h–2 535.9555 450.1285 482.2046 450.8902 Group 1
0h–3 523.0573 441.1327 471.8197 439.5416 Group 1
0h–4 506.8386 416.3425 461.1772 428.2384 Group 1
0h–5 506.4268 420.5351 459.7598 425.3151 Group 1
0h–6 497.6219 410.4663 454.6204 417.8401 Group 1
4h–1 620.1771 724.5048 568.5795 537.1318 Group 2
4h–2 576.3855 658.6562 531.7202 500.3762 Group 2
4h–3 613.4444 697.7508 558.4109 521.3005 Group 2
8h–1 230.7888 149.0967 285.5434 248.079 Group 2
8h–2 222.345 131.3232 277.1254 242.1758 Group 3
8h–3 273.8767 167.6216 320.4036 286.5982 Group 3
12h–1 239.249 141.7303 279.4635 232.1544 Group 3
12h–2 252.1497 147.359 288.996 243.3182 Group 3
16h–1 226.2616 146.0414 284.8936 258.7989 Group 3
16h–2 214.081 138.1432 277.3383 243.8137 Group 3
16h–3 299.1992 209.131 342.5529 324.0587 Group 3
24h–1 334.845 226.4543 369.0168 407.3281 Group 4
24h–2 347.7744 261.7876 379.8865 406.6919 Group 4
24h–3 315.3767 225.3518 365.1568 383.219 Group 4
32h–1 286.9952 195.4727 332.1823 371.5529 Group 4
32h–2 299.0332 218.8288 343.1931 380.1826 Group 4
32h–3 261.7968 184.9235 319.7706 334.5194 Group 4
40h–1 262.8648 167.8326 324.1094 366.8979 Group 4
40h–2 257.8077 169.8686 316.6211 362.3634 Group 4
40h–3 254.5887 184.1729 319.7806 350.5959 Group 4
48h–1 262.8003 143.5924 312.7345 351.9222 Group 4
48h–2 253.5572 148.9475 305.4050 346.3333 Group 4
48h–3 338.3254 267.6897 379.5001 421.7295 Group 4
Note: Group 1 denotes samples of 0 h (R-PMR), Group2denotes samples of 4 h, Group 3 denotes samples of 8 to 16 h and Group 4 denotes samples of 24 to 48 h
To show the regular change of P-PMR samples with differ-
ence in processing time, it was essential to compare the con-
tent of screening 14 markers in different groups. Figure 1B
showed the total ion chromatogram (TIC) of 14 markers in
the four groups. As shown in Fig. 5, the average intensity
of M133, M179, M215, M278, M389 and M517 improved
with the processing times 0–48 h, after which the contents
showed no regular changes. With the increasing time of
processing, the average intensity of M341, M377, M379,
M404, M439, M440 and M683 were decreased. However,
M169 (gallic acid) presented a completely opposite tendency.
The content of gallic acid was increased as the processing
times increased. As a result, processing could affect the con-
tents of components in PMR and pharmacological effects
of PMR, which need to carry out a deep research on this
phenomenon.
4 CONCLUDING REMARKS
The UHPLC–Q-TOF-MS-based metabolomics method was
developed and validated for the evaluation of the influence
of different processing times on the quality of PMR. Princi-
pal component analysis and Partial Least Squares Discrim-
inant Analysis was successfully applied to screen the 35
maker metabolites, which were used to establish the discrim-
inant models in the Fisher’s discriminant analysis. With the
approach, different PMR samples, which are commercially
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TABLE 5 The prediction of 35 sample depending on the four different discriminant functions scores
Discriminant functions score
Sample name Group 1 Group 2 Group 3 Group 4 Prediction
S1 495.1874 396.0188 443.9055 404.5508 Group 1
S2 569.9564 475.8026 503.4594 467.9002 Group 1
S3 481.3273 394.9448 440.2833 405.2898 Group 1
S4 451.3689 343.7183 429.8273 398.7956 Group 1
S5 542.5472 466.388 490.1531 470.6152 Group 1
S6 481.8308 391.022 434.2839 385.6863 Group 1
S7 505.8627 397.4449 452.3316 421.6209 Group 1
S8 552.9518 473.4268 499.565 468.7872 Group 1
S9 562.4498 481.9678 497.7762 466.9084 Group 1
S10 541.1245 439.22 481.157 458.5999 Group 1
S11 519.2018 452.041 464.2325 427.2706 Group 1
S12 483.5436 361.9699 446.5619 404.2643 Group 1
Z1 − 542.224 − 697.332 − 312.926 − 440.369 Group 3
Z2 − 125.898 − 302.42 32.95553 − 36.362 Group 3
Z3 568.6966 720.4801 538.6208 632.584 Group 2
Z4 − 123.735 − 278.387 37.18831 − 43.1512 Group 3
Z5 488.1378 713.6765 492.5701 553.6499 Group 2
Z6 − 323.377 − 546.953 − 138.732 − 250.873 Group 3
Z7 − 497.102 − 787.988 − 298.719 − 496.738 Group 3
Z8 93.13856 81.82741 173.2194 179.7277 Group 4
Z9 − 379.549 − 578.719 − 190.125 − 394.103 Group 3
Z10 149.3714 120.1374 231.8514 209.0509 Group 3
Z11 295.1615 142.8508 324.7297 383.072 Group 4
Z12 308.1999 322.2907 343.3908 391.0132 Group 4
Z13 214.7621 293.449 273.225 326.784 Group 4
Z14 347.636 399.8933 369.4687 471.3786 Group 4
Z15 38.19232 − 2.53979 156.111 188.6083 Group 4
Z16 − 378.665 − 491.944 − 181.058 − 275.225 Group 3
Z17 − 108.522 − 249.099 22.99999 − 8.14454 Group 3
Z18 − 123.489 − 244.781 10.92012 − 28.0452 Group 3
Z19 118.5649 93.63506 187.6745 169.4295 Group 3
Z20 167.3504 143.5854 236.1682 290.5901 Group 4
Z21 385.5307 353.8848 401.8973 440.4527 Group 4
Z22 183.3692 191.1503 249.4224 292.7976 Group 4
Z23 122.3098 − 158.092 187.556 160.7807 Group 3
Note: S1–12 present R-PMR sample. Z1–22 2 present P-PMR sample. Group 1 denotes samples of 0 h (R-PMR), Group 2 denotes samples of 4 h, Group 3 denotes samples
of 8 to 16 h and Group 4 denotes samples R of 24 to 48 h.
available in the market, could be precisely classified using
the detected metabolites. The R-PMR samples and P-PMR
samples could be distinguished. The results showed that
the 12R-PMR samples belonged to the group of process-
ing time of 0 h while two processed PMR samples were
part of the group of processing times of 4 h, 12 samples
belonged to group of processing times of 8–16 h and nine
samples were part of the group of processing times of 20
to 48 h. The results confirmed the validity of the metabolite
profiling study. Consequently, the method could help in
the precise authentication of PMR and could also be
applied for the processing standardization of PMR in the
markets.
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